Unknown

Dataset Information

0

Unique structural modifications are present in the lipopolysaccharide from colistin-resistant strains of Acinetobacter baumannii.


ABSTRACT: Acinetobacter baumannii is a nosocomial opportunistic pathogen that can cause severe infections, including hospital-acquired pneumonia, wound infections, and sepsis. Multidrug-resistant (MDR) strains are prevalent, further complicating patient treatment. Due to the increase in MDR strains, the cationic antimicrobial peptide colistin has been used to treat A. baumannii infections. Colistin-resistant strains of A. baumannii with alterations to the lipid A component of lipopolysaccharide (LPS) have been reported; specifically, the lipid A structure was shown to be hepta-acylated with a phosphoethanolamine (pEtN) modification present on one of the terminal phosphate residues. Using a tandem mass spectrometry platform, we provide definitive evidence that the lipid A isolated from colistin-resistant A. baumannii MAC204 LPS contains a novel structure corresponding to a diphosphoryl hepta-acylated lipid A structure with both pEtN and galactosamine (GalN) modifications. To correlate our structural studies with clinically relevant samples, we characterized colistin-susceptible and -resistant isolates obtained from patients. These results demonstrated that the clinical colistin-resistant isolate had the same pEtN and GalN modifications as those seen in the laboratory-adapted A. baumannii strain MAC204. In summary, this work has shown complete structure characterization including the accurate assignment of acylation, phosphorylation, and glycosylation of lipid A from A. baumannii, which are important for resistance to colistin.

SUBMITTER: Pelletier MR 

PROVIDER: S-EPMC3811424 | biostudies-literature | 2013 Oct

REPOSITORIES: biostudies-literature

altmetric image

Publications

Unique structural modifications are present in the lipopolysaccharide from colistin-resistant strains of Acinetobacter baumannii.

Pelletier Mark R MR   Casella Leila G LG   Jones Jace W JW   Adams Mark D MD   Zurawski Daniel V DV   Hazlett Karsten R O KR   Doi Yohei Y   Ernst Robert K RK  

Antimicrobial agents and chemotherapy 20130722 10


Acinetobacter baumannii is a nosocomial opportunistic pathogen that can cause severe infections, including hospital-acquired pneumonia, wound infections, and sepsis. Multidrug-resistant (MDR) strains are prevalent, further complicating patient treatment. Due to the increase in MDR strains, the cationic antimicrobial peptide colistin has been used to treat A. baumannii infections. Colistin-resistant strains of A. baumannii with alterations to the lipid A component of lipopolysaccharide (LPS) have  ...[more]

Similar Datasets

| S-EPMC4776000 | biostudies-literature
| S-EPMC4462660 | biostudies-literature
| S-EPMC7097930 | biostudies-literature
| S-EPMC6198730 | biostudies-literature
2021-01-12 | PXD020218 | Pride
| S-EPMC3071218 | biostudies-literature
| S-EPMC2981237 | biostudies-literature
| S-EPMC8780235 | biostudies-literature
| S-EPMC7183746 | biostudies-literature
| S-EPMC6635527 | biostudies-literature